BioNTech
BioNTech
BioNTech (pronounced: /ˈbaɪ.oʊˌtɛk/) is a German biotechnology company that specializes in the research and development of mRNA-based vaccines and immunotherapy treatments for cancer and infectious diseases.
Etymology
The name "BioNTech" is an abbreviation of "Biopharmaceutical New Technologies". It reflects the company's focus on the development of new technologies in the field of biopharmaceuticals.
History
BioNTech was founded in 2008 by Uğur Şahin, Özlem Türeci, and Christoph Huber. The company is headquartered in Mainz, Germany. BioNTech gained international recognition in 2020 for developing the first widely approved COVID-19 vaccine, in collaboration with Pfizer.
Related Terms
- mRNA: A type of RNA molecule that carries the genetic instructions from DNA in a cell's nucleus to the ribosome, where it specifies the sequence of amino acids in a protein.
- Vaccine: A biological preparation that provides active acquired immunity to a particular infectious disease.
- Immunotherapy: A type of cancer treatment that helps your immune system fight cancer.
- Biotechnology: The use of living systems and organisms to develop or make products.
- Pfizer: An American multinational pharmaceutical corporation.
- COVID-19 vaccine: A vaccine intended to provide acquired immunity against COVID-19.
External links
- Medical encyclopedia article on BioNTech
- Wikipedia's article - BioNTech
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski